CN102451363A - 中草药减肥茶 - Google Patents
中草药减肥茶 Download PDFInfo
- Publication number
- CN102451363A CN102451363A CN201010526728XA CN201010526728A CN102451363A CN 102451363 A CN102451363 A CN 102451363A CN 201010526728X A CN201010526728X A CN 201010526728XA CN 201010526728 A CN201010526728 A CN 201010526728A CN 102451363 A CN102451363 A CN 102451363A
- Authority
- CN
- China
- Prior art keywords
- grams
- herbal medicine
- chinese herbal
- gram
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000411851 herbal medicine Species 0.000 title claims abstract description 38
- 241001122767 Theaceae Species 0.000 title claims 11
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 235000005911 diet Nutrition 0.000 claims description 50
- 230000037213 diet Effects 0.000 claims description 50
- 241000628997 Flos Species 0.000 claims description 34
- 239000003814 drug Substances 0.000 claims description 23
- 210000000582 semen Anatomy 0.000 claims description 20
- 230000003203 everyday effect Effects 0.000 claims description 14
- 239000008361 herbal raw material Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 6
- 235000012054 meals Nutrition 0.000 claims description 6
- 239000002893 slag Substances 0.000 claims description 6
- 244000269722 Thea sinensis Species 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 29
- 230000001737 promoting effect Effects 0.000 abstract description 13
- 206010012735 Diarrhoea Diseases 0.000 abstract description 11
- 235000007516 Chrysanthemum Nutrition 0.000 abstract description 4
- 210000000577 adipose tissue Anatomy 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000220317 Rosa Species 0.000 abstract 1
- 239000003925 fat Substances 0.000 description 38
- 210000004369 blood Anatomy 0.000 description 37
- 239000008280 blood Substances 0.000 description 37
- 235000013616 tea Nutrition 0.000 description 29
- 210000004185 liver Anatomy 0.000 description 17
- 210000000952 spleen Anatomy 0.000 description 15
- 206010010774 Constipation Diseases 0.000 description 14
- 208000008589 Obesity Diseases 0.000 description 13
- 230000037396 body weight Effects 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 235000020824 obesity Nutrition 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 208000019790 abdominal distention Diseases 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000022531 anorexia Diseases 0.000 description 5
- 206010061428 decreased appetite Diseases 0.000 description 5
- 230000002124 endocrine Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000016261 weight loss Diseases 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 238000009534 blood test Methods 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 201000010251 cutis laxa Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 3
- 241000723353 Chrysanthemum Species 0.000 description 3
- 239000010282 Emodin Substances 0.000 description 3
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 3
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 3
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 3
- 230000004768 organ dysfunction Effects 0.000 description 3
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 238000003748 differential diagnosis Methods 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- CBOKHFLBNZMMAA-UHFFFAOYSA-N Emodin anthrone Natural products OC1=CC(O)=CC2=CC3=CC(C)=CC(O)=C3C(O)=C21 CBOKHFLBNZMMAA-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000698291 Rugosa Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- -1 cholesteryl ester Chemical class 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000000188 diaphragm Anatomy 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- LAJSXCAVRQXZIO-UHFFFAOYSA-N emodin anthrone Chemical compound C1=C(O)C=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O LAJSXCAVRQXZIO-UHFFFAOYSA-N 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 235000015091 medicinal tea Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
- 229960004425 sibutramine Drugs 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种中草药减肥茶,由以下中草药原料配制而成:山楂4-10g、决明子4-10g、荷叶2-8g、制何首乌3-5g、白菊花1-3g、百合4-10g、陈皮3-5g、桑叶2-4g、玫瑰花2-4g;该减肥茶通过冲泡的方式饮用,能够被人体有效吸收,通过促进脂肪代谢,使过多的体内脂肪得到及时的分解代谢,不产生腹泻现象,用后不反弹,阻止多余脂肪在体内储存,保持体重在一定的健康范围内,并具有一定的美容效果。
Description
技术领域
本发明涉及一种减肥茶,具体涉及的是由决明子、荷叶、玫瑰花等中草药配制而成的减肥茶。
背景技术
肥胖是一种世界性的健康疾病,主要是由于人体内脂肪,尤其是甘油三酯积聚过多所致,分为单纯性肥胖和病理性肥胖两大类。一般所指的肥胖为单纯性肥胖,是由于在饮食过程中所摄入的热量,大大超过其本身所消耗的热量,而使多余的脂肪及其他养料在体内积蓄起来形成脂肪细胞,而导致肥胖。国家卫生部门一项调查结果,公布了我国肥胖人群增长状况,四十岁以上者占多数,女性发病率较高。但近几年来,少年儿童和青少年的发胖率也快速增长,已引起高度重视。肥胖不仅影响工作、生活、美观,而且对健康有一定的危害。世界卫生组织已经将肥胖定为疾病,是目前继心脑血管疾病和癌症之后对人类健康威胁的第三大敌人。
肥胖患者易发生高血压、冠心病、脂肪肝、糖尿病、高血脂、痛风及胆结石等疾病。单纯性肥胖疾病患者通过临床化验,绝大多数患者出现内分泌紊乱,尤其是高胰岛素血症、糖耐量实验异常、性激素水平紊乱、肾上腺皮质激素增高等等。如对肥胖疾病的早期治疗可以截断上述疾病的发生。目前,治疗肥胖的药物很多,如盐酸西布曲明、奥利司他、瘦素等,但其作用机理主要是以抑制食欲为主,对肝脏、肾脏功能伤害极大,且药剂量大,次数多,治愈费用高,并且在停药后会出现反弹迹象,而现有的含有部分中药成分的减肥药物主要是以排泄通便为主,容易出现电解质失衡和分泌系统紊乱等副作用,配方不科学。在药物减肥效果不理想,药物副作用大的情况下,中药减肥茶从中脱颖而出,因其纯天然养生且方便的优势而越来越受到减肥人士的钟爱。
中草药减肥备受推崇,主要原因还是因为中草药减肥相比西药更加安全,没有副作用,不用烦恼和担心减掉肥肉脂肪的同时也减到健康。传统中医认为,肥胖主要与痰、湿、气虚等有关,因此,采用中草药减肥,应从益气、健脾、化痰等着手,利用中药减肥的优势,调整人体各器官恢复原有功能,恢复人体能量代谢,从而达到健康减肥的目的。30岁以下的年轻人会胖,大部分原因是由于饮食多油腻,加上工作和生活的压力等,人体内并产生了多余的热,造成亢进现象。以中药减肥角度来讲,除了消脂、利尿外,最要紧的是要清热,让身体代谢功能恢复正常。决明子正是平肝息风的良药。决明子性微寒,味甘,归肝、肾、大肠经。微寒清热,苦以降泄,主入肝经,长于清肝明目,且味甘,兼益肾阴,可以降血压、降血脂肪,还能通便,达到清热的效果。中医理论里提倡益气,“肝郁则侮脾”,使其顺畅的系统在肝,消化代谢不完全自然就容易胖。并且以年轻女性居多,较常见的症状为胸闷、肚子发胀,情绪容易起伏不定,严重的还会导致月经失调。加上这一类人倾向用吃东西来纾解情绪,所以更易导致体重偏胖。玫瑰花具有良好的理气效果,其玫瑰味浓醇回甜,香气馥郁,可解油腻,助消化,除腹胀,生津止渴,减肥健美,但主要以理气效果为主,必须搭配其他药材才能达到减肥效果。荷叶更是自古以来就被奉为减肥瘦身的良药,“荷叶减肥,令人瘦劣”。荷叶茶主要作用有分解脂肪、消除便秘、利尿,还能降低血清中甘油三醇和胆固醇含量,具有调节血脂的保健作用,饮用一段时间后,能改变饮用者对荤腥油腻的食物的喜好,从而达到不用节食就能减肥的目的。中国专利CN101596256A所公布减肥茶配方中含有玳玳花、龙井茶、扁豆、制大黄、决明子、荷叶等成分,其配方未依据中医辩证疗法,药物配伍不合理,治疗效果不明显,服用后易产生腹泻等副作用。
发明内容
本发明的目的在于解决现有技术的不足,提供一种中草药减肥茶,该减肥茶采用中草药全新配方,它能够被人体有效吸收,调节人体新陈代谢,保持各器官功能协调,从而达到降脂,通便的功效。
本发明的目的是通过如下的技术方案来实现的:
中草药减肥茶,其特征在于:由以下中草药原料配制而成:
山楂4-10克、决明子4-10克、荷叶2-8克、制何首乌3-5克、白菊花1-3克、百合4-10克、陈皮3-5克、桑叶2-4克、玫瑰花2-4克;
所述中草药减肥茶的制备方法是:将上述中药材原料按其重量配比配制后,加入2-3倍清水浸泡40-60分钟后,用大火煎沸后改用小火煎煮30-40分钟,去渣取汁,包装成袋,得到中药方剂成品。
所述中草药减肥茶的用法为:每日两次,每次一袋,饭前半小时或饭后半小时饮用,30天为一个疗程,治疗期间应注重合理饮食,避免高热量及油腻食物,并配合适量的有氧运动。
本发明中草药减肥茶,其配方作用机理是:
山楂能够健胃消食、调节血脂,决明子能够润肠通便、降低血清胆固醇,荷叶能有效阻止脂肪的吸收,何首乌能够养血、润肠通便、降低血脂,白菊花能够降低血清甾醇和三酸甘油脂,百合能够健脾和胃、治疗腹胀、益气美容,陈皮能够治疗脾胃气滞湿阻,桑叶能够降低血糖、血脂、利尿,玫瑰花能够平衡内分泌、补血气、助消化、润肠通便、消脂肪、美颜护肤,通过运用上述各成分的作用机理,采用冲泡的饮用方式,配合合理饮食和适量的有氧运动,促进脂肪代谢,使过多的体内脂肪得到及时的分解代谢,不产生腹泻现象,保持各器官功能协调,阻止多余脂肪在体内储存,保持体重在一定的健康范围内,并具有一定的美容效果。
本发明中草药减肥茶,其配方各成分功效是:
山楂:以果实作药用,性微温,味酸甘,归脾、胃、肝经;中医认为,山楂有消食健胃、化滞消积、活血散瘀、化痰行气之功能,用于肉食滞积、症瘕积聚、腹胀痞满、瘀阻腹痛、痰饮、泄泻、肠风下血等;现代医学研究证明山楂含有多种维生素、山楂酸、酒石酸、柠檬酸、苹果酸等,还含有黄酮类、内酯、糖类、蛋白质、脂肪和钙、磷、铁等矿物质,所含的解脂酶能促进脂肪类食物的消化;促进胃液分泌和增加胃内酶素等功能;山楂中含有山萜类及黄酮类等药物成分,具有显著的扩张血管及降压作用,有增强心肌、抗心律不齐、调节血脂及胆固醇含量的功能;
决明子:以种子作药用,性平,味微苦微甘,微凉,归肝、肾、大肠经;中医认为,决明子有清热明目,润肠通便之功效,用于目赤涩痛,羞明多泪,头痛眩晕,目暗不明,大便秘结等;现代医学研究表明,决明子除含有糖类、蛋白质、脂肪外,还含甾体化合物、大黄酚、大黄素等,还有人体必需的微量元素铁、锌、锰、铜、镍、钴、钼等;所含大黄素、大黄酸对人体有平喘、利胆、保肝、降压功效,并有一定抗菌、消炎作用;其中大黄素葡萄糖甙、大黄素蒽酮、大黄素甲醚,具有降低血清胆固醇和强心作用;决明子素具有a-羟基,可与金属素合成络合物,对金属元素吸收有很大影,现代临床用决明子治疗高脂血症收效满意;
荷叶:味苦辛微涩、性凉,归心、肝、脾经;中医认为,荷叶具有消暑利湿,健脾升阳,散瘀止血的功效,主治暑热烦渴,头痛眩晕,水肿,食少腹胀,泻痢,白带,脱肛,吐血,衄血,咯血,便血,崩漏,产后恶露不净,损伤瘀血;现代医学研究证明,荷叶内含有荷叶碱,荷叶碱可扩张血管,清热解暑,具有降血压的作用,同时还是减肥的良药,荷叶碱减肥原理是,即服用后在人体肠壁上形成一层脂肪隔离膜,有效阻止脂肪的吸收,从根本上减重,并更有效的控制反弹;
何首乌:以干燥根块作药用,味苦、甘、涩,性微温;归肝,肾经;中医认为,何首乌有养血滋阴,润肠通便,截疟,祛风,解毒之功效,主治血虚头昏目眩,心悸,失,肝肾阴虚之腰膝酸软,须发早白,耳鸣,遗精,肠燥便秘,久疟体虚,风疹瘙痒,疮痈,瘰疬,痔疮;现代医学研究证明,何首乌具有降血脂及抗动脉粥样硬化等作用,实验研究表明,制何首乌醇提取物0.84~8.4g/kg·d灌胃给药,6周内可显著降低老年鹌鹑的血浆甘油三酯和游离胆固醇水平,抑制血浆总胆固醇和胆固醇酯的升高;制何首乌的水提物可明显提高小鼠血清高密度脂蛋白胆固醇含量,降低TC水平,结合HDL-C/TC比值显著升高,提示何首乌可提高机体运转和清除胆固醇的能力,降低血脂水平,延缓动脉粥样硬化的发展;
白菊花:味微辛,甘,苦,性微寒,归肺、肝经;中医认为,白菊花能疏散风热,清肝明目,平肝阳,解毒;现代医学研究证明,菊中含有有效化学成分,如腺嘌呤、胆碱、水苏碱等,从菊中提炼出来的挥发油,含有菊花酮、龙脑、乙酸龙脑酯等。药理实验证明,白菊煎剂对宋氏痢疾杆菌、变形杆菌、伤寒杆菌、副伤寒杆菌、绿脓杆菌、大肠杆菌及霍乱弧菌等都有抑制作用。常服菊花煎剂,对心脏有明显扩冠和增加冠脉流量,能降低血清甾醇和三酸甘油脂,并能降压预防心绞痛;白菊还可代茶,其色、香、味不亚于龙井茶;经常服用,能增强毛细血管抵抗力、抑制毛细血管的通性,起到抗炎强身作用;
百合:性微寒,能清心除烦,宁心安神,入心经;中医认为,百合用于热病后余热未消、神思恍惚、失眠多梦、心情抑郁、喜悲伤欲哭等病症;百合具有润肺止咳,清心安神,补中益气,清热利尿,清热解毒,健脾和胃;治失眠多梦,烦燥不安,心痛,喉痹,胃阴不足之胃痛,二便不利,浮肿,痈肿疮毒,脚气,产后出血,腹胀,身痛;
陈皮:性温,味辛、苦,归脾、肺经;中医认为,陈皮具理气降逆、调中开胃、燥湿化痰之功,主治脾胃气滞湿阻、胸膈满闷、脘腹胀痛、不思饮食、呕吐秽逆、二便不利、肺气阻滞、咳嗽痰多,亦治乳痈初起;经多年研究,陈皮可用于脾虚饮食减少、消化不良,以及恶心呕吐等症;陈皮燥湿而能健脾开胃,适用于脾胃虚弱、饮食减少、消化不良、大便泄泻等症;
桑叶:味甘,苦;性寒,归肺,肝经;现代医学研究证明,桑叶有降血糖作用,其所含的蜕皮甾酮对多种方法诱导的血糖升高均有降糖作用,可促进葡萄糖转化为糖元,但不改变正常动物的血糖;桑叶还具有降血脂、利尿等作用;桑叶有抗病原微生物作用,桑叶煎剂在体外试验对金黄色葡萄球菌、乙型溶血性链球菌、白喉杆菌和大肠杆菌等均有一定抑制作用;
玫瑰花:味辛、甘,性微温;中医认为,玫瑰花能理气解郁,化湿和中,活血散瘀,利气,行血,治风痹,散疲止痛;现代医学研究证明,玫瑰花性质温和,可缓和情绪、平衡内分泌、补血气,美颜护肤、对肝及胃有调理的作用、并可消除疲劳、改善体质玫瑰花还有助消化、消脂肪之功效,因而可减肥,最适合因内分泌紊乱而引起肥胖的患者,最重要的是它的养颜美容功效,常饮可去除皮肤上的黑斑,令皮肤嫩白自然,防皱纹也有帮助;肝郁气滞型的减肥可多饮用,有助于减肥;除此之外,还具有润肠通便的功效。
本发明与现有技术相比,具有以下技术效果:
1、本发明采用中草药全新配方,通过中医辩证施治的理论,通过滋阴清胃火,健脾胃,通腑理气,通便利尿,利肝胆湿热,调节内分泌,从而达到减肥降脂,降低血脂浓度,润肠通便,清热利湿的功效。
2、本发明能够被人体有效吸收,通过促进脂肪代谢,使过多的体内脂肪得到及时的分解代谢,不产生腹泻现象,保持各器官功能协调,阻止多余脂肪在体内储存,保持体重在一定的健康范围内,并具有一定的美容效果。
3、本发明采用中草药全新配方,各配方用量相互作用,构成一个完整的技术方案,具有减肥降脂效果明显,用后不反弹,成本低廉等优点。
具体实施方式
实施例1
中草药减肥茶,其特征在于:由以下中草药原料配制而成:
山楂4克、决明子4克、荷叶2克、制何首乌3克、白菊花1克、百合4克、陈皮3克、桑叶2克、玫瑰花2克;
所述中草药减肥茶的制备方法是:将上述中药材原料按其重量配比配制后,加入2倍清水浸泡40分钟后,用大火煎沸后改用小火煎煮30分钟,去渣取汁,包装成袋,得到中药方剂成品。
所述中草药减肥茶的用法为:每日两次,每次一袋,饭前半小时饮用,30天为一个疗程,治疗期间应注重合理饮食,避免高热量及油腻食物,并配合适量的有氧运动。
实施例2
中草药减肥茶,其特征在于:由以下中草药原料配制而成:
山楂10克、决明子10克、荷叶8克、制何首乌5克、白菊花3克、百合10克、陈皮5克、桑叶4克、玫瑰花4克;
所述中草药减肥茶的制备方法是:将上述中药材原料按其重量配比配制后,加入3倍清水浸泡60分钟后,用大火煎沸后改用小火煎煮40分钟,去渣取汁,包装成袋,得到中药方剂成品。
所述中草药减肥茶的用法为:每日两次,每次一袋,饭前半小时饮用,30天为一个疗程,治疗期间应注重合理饮食,避免高热量及油腻食物,并配合适量的有氧运动。
实施例3
中草药减肥茶,其特征在于:由以下中草药原料配制而成:
山楂6克、决明子6克、荷叶5克、制何首乌4克、白菊花2克、百合6克、陈皮4克、桑叶3克、玫瑰花3克;
所述中草药减肥茶的制备方法是:将上述中药材原料按其重量配比配制后,加入2.5倍清水浸泡45分钟后,用大火煎沸后改用小火煎煮35分钟,去渣取汁,包装成袋,得到中药方剂成品。
所述中草药减肥茶的用法为:每日两次,每次一袋,饭后半小时饮用,30天为一个疗程,治疗期间应注重合理饮食,避免高热量及油腻食物,并配合适量的有氧运动。
实施例4
中草药减肥茶,其特征在于:由以下中草药原料配制而成:
山楂8克、决明子8克、荷叶7克、制何首乌5克、白菊花2克、百合8克、陈皮3克、桑叶3克、玫瑰花2克;
所述中草药减肥茶的制备方法是:将上述中药材原料按其重量配比配制后,加入3倍清水浸泡50分钟后,用大火煎沸后改用小火煎煮40分钟,去渣取汁,包装成袋,得到中药方剂成品。
所述中草药减肥茶的用法为:每日两次,每次一袋,饭后半小时饮用,30天为一个疗程,治疗期间应注重合理饮食,避免高热量及油腻食物,并配合适量的有氧运动。
下列为本发明的试用效果案例:
案例一:陈某,女,32岁,单纯性肥胖症患者,体重超过标准体重20%。陈某每日按照实施例1成分配比饮用减肥茶,每日两次,每次饭前半小时饮用,连续饮用一个疗程后,测定各项指标,结果表明,陈某体重下降3公斤,腰围减小4.5厘米,臀围减小3厘米,运动耐力增强,未见肌饿、厌食、乏力、腹泻等副作用,减肥后无皮肤松弛,血常规、生化指标无异常。
案例二:张某,男,45岁,是一名单纯性肥胖患者,体重超过标准体重的35%,血脂、血糖偏高,单纯性肥胖患者由于饮食无节制,机体内热量摄入大于自身消耗,脂肪在体内积聚过多,造成体重超常。张某每日按照实施例2成分配比饮用减肥茶,每日两次,每次饭前半小时饮用,连续饮用一个疗程后,测定各项指标,结果表明,张某体重下降4公斤,腰围减小5厘米,臀围减小3厘米,血脂、血糖也明显下降,未见肌饿、厌食、乏力、腹泻等副作用,减肥后无皮肤松弛,血常规、生化指标无异常。
案例三:李某,女,50岁,单纯性肥胖症患者,体重超过标准体重25%,血脂偏高,李某每日按照实施例3成分配比饮用减肥茶,每日两次,每次饭后半小时饮用,连续饮用一个疗程后,测定各项指标,结果表明,李某体重下降4.5公斤,腰围减小6厘米,臀围减小4厘米,血脂也明显下降,运动耐力增强,未见肌饿、厌食、乏力、腹泻等副作用,减肥后无皮肤松弛,血常规、生化指标无异常。
案例四:肖某,男,55岁,单纯性肥胖症患者,体重超过标准体重30%,血脂偏高,肖某每日按照实施例4成分配比饮用减肥茶,每日两次,每次饭后半小时饮用,连续饮用一个疗程后,测定各项指标,结果表明,陈某体重下降4公斤,腰围减小4.5厘米,臀围减小2厘米,血脂也明显下降,运动耐力增强,未见肌饿、厌食、乏力、腹泻等副作用,减肥后无皮肤松弛,血常规、生化指标无异常。
Claims (7)
1.中草药减肥茶,其特征在于:由以下中草药原料配制而成:
山楂4-10克、决明子4-10克、荷叶2-8克、制何首乌3-5克、白菊花1-3克、百合4-10克、陈皮3-5克、桑叶2-4克、玫瑰花2-4克。
2.根据权利要求1所述的中草药减肥茶,其特征在于:由以下中草药原料配制而成:
山楂4克、决明子4克、荷叶2克、制何首乌3克、白菊花1克、百合4克、陈皮3克、桑叶2克、玫瑰花2克。
3.根据权利要求1所述的中草药减肥茶,其特征在于:由以下中草药原料配制而成:
山楂10克、决明子10克、荷叶8克、制何首乌5克、白菊花3克、百合10克、陈皮5克、桑叶4克、玫瑰花4克。
4.根据权利要求1所述的中草药减肥茶,其特征在于:由以下中草药原料配制而成:
山楂6克、决明子6克、荷叶5克、制何首乌4克、白菊花2克、百合6克、陈皮4克、桑叶3克、玫瑰花3克。
5.根据权利要求1所述的中草药减肥茶,其特征在于:由以下中草药原料配制而成:
山楂8克、决明子8克、荷叶7克、制何首乌5克、白菊花2克、百合8克、陈皮3克、桑叶3克、玫瑰花2克。
6.根据权利要求1-5任一项所述的中草药减肥茶,其特征在于:中草药减肥茶的制备方法为:所述中草药减肥茶的制备方法是:将上述中药材原料按其重量配比配制后,加入2-3倍清水浸泡40-60分钟后,用大火煎沸后改用小火煎煮30-40分钟,去渣取汁,包装成袋,得到中药方剂成品。
7.根据权利要求6所述的中草药减肥茶,其特征在于:中草药减肥茶的使用法为:每日两次,每次一袋,饭前半小时或饭后半小时饮用,30天为一个疗程,治疗期间应注重合理饮食,避免高热量及油腻食物,并配合适量的有氧运动。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010526728XA CN102451363A (zh) | 2010-10-28 | 2010-10-28 | 中草药减肥茶 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010526728XA CN102451363A (zh) | 2010-10-28 | 2010-10-28 | 中草药减肥茶 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102451363A true CN102451363A (zh) | 2012-05-16 |
Family
ID=46035306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010526728XA Pending CN102451363A (zh) | 2010-10-28 | 2010-10-28 | 中草药减肥茶 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102451363A (zh) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102885900A (zh) * | 2012-10-10 | 2013-01-23 | 湖北省宏源药业有限公司 | 一种具有减肥功能组合物及其制备方法 |
CN103190659A (zh) * | 2013-04-12 | 2013-07-10 | 康美药业股份有限公司 | 具有降压降脂和降糖作用的植物饮料及其制备方法和应用 |
CN103446426A (zh) * | 2013-01-14 | 2013-12-18 | 贾晋科 | 一种降血压、降血脂的中药泡茶 |
CN103445184A (zh) * | 2013-07-26 | 2013-12-18 | 杨德俊 | 一种保健人参瘦身胶原蛋白粉 |
CN103549078A (zh) * | 2013-10-25 | 2014-02-05 | 何运仲 | 一种排毒瘦身茶及其制备方法 |
CN103609796A (zh) * | 2013-11-28 | 2014-03-05 | 诸暨企航企业管理咨询有限公司 | 一种功夫保健茶 |
CN103719476A (zh) * | 2012-10-16 | 2014-04-16 | 广西北流市一品黑土特产销售中心 | 一种中草药润肠通便茶 |
CN103749809A (zh) * | 2013-12-20 | 2014-04-30 | 福建农林大学 | 一种清燥降脂养生茶及其制备方法 |
CN104186838A (zh) * | 2014-08-19 | 2014-12-10 | 安徽孟氏中药饮片有限公司 | 一种保健五色花茶及其制备方法 |
CN104522780A (zh) * | 2014-12-24 | 2015-04-22 | 广州至信中药饮片有限公司 | 降压清肠保健药膳及其制备方法 |
CN105558129A (zh) * | 2015-12-14 | 2016-05-11 | 华坚 | 一种百合养颜茶及其制备方法 |
CN105832890A (zh) * | 2016-05-27 | 2016-08-10 | 孙明香 | 一种防治单纯性肥胖的保健饮品及其制备方法 |
CN106106901A (zh) * | 2016-08-31 | 2016-11-16 | 冯键业 | 养生减肥茶 |
CN109260405A (zh) * | 2017-07-13 | 2019-01-25 | 张巧英 | 一种养生药酒药醋 |
CN111228372A (zh) * | 2020-03-12 | 2020-06-05 | 厦门旗腾文化传媒有限公司 | 一种草本发酵平衡液及其制备方法 |
CN114794467A (zh) * | 2022-04-12 | 2022-07-29 | 广州市沐家健康产业有限公司 | 一种果蔬酵素咀嚼片及其制备方法和应用 |
CN115487268A (zh) * | 2022-09-30 | 2022-12-20 | 广州聚缘堂丹道药业科技有限公司 | 一种促进血液循环和毒素代谢的组合物及其制备方法 |
CN117180340A (zh) * | 2023-11-08 | 2023-12-08 | 吉林华康食元生物科技有限公司 | 一种降血脂的组合物及其制备方法和应用 |
-
2010
- 2010-10-28 CN CN201010526728XA patent/CN102451363A/zh active Pending
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102885900B (zh) * | 2012-10-10 | 2013-09-25 | 湖北省宏源药业有限公司 | 一种具有减肥功能组合物及其制备方法 |
CN102885900A (zh) * | 2012-10-10 | 2013-01-23 | 湖北省宏源药业有限公司 | 一种具有减肥功能组合物及其制备方法 |
CN103719476A (zh) * | 2012-10-16 | 2014-04-16 | 广西北流市一品黑土特产销售中心 | 一种中草药润肠通便茶 |
CN103446426A (zh) * | 2013-01-14 | 2013-12-18 | 贾晋科 | 一种降血压、降血脂的中药泡茶 |
CN103190659A (zh) * | 2013-04-12 | 2013-07-10 | 康美药业股份有限公司 | 具有降压降脂和降糖作用的植物饮料及其制备方法和应用 |
CN103445184A (zh) * | 2013-07-26 | 2013-12-18 | 杨德俊 | 一种保健人参瘦身胶原蛋白粉 |
CN103549078A (zh) * | 2013-10-25 | 2014-02-05 | 何运仲 | 一种排毒瘦身茶及其制备方法 |
CN103609796B (zh) * | 2013-11-28 | 2015-11-11 | 诸暨企航企业管理咨询有限公司 | 一种功夫保健茶 |
CN103609796A (zh) * | 2013-11-28 | 2014-03-05 | 诸暨企航企业管理咨询有限公司 | 一种功夫保健茶 |
CN103749809A (zh) * | 2013-12-20 | 2014-04-30 | 福建农林大学 | 一种清燥降脂养生茶及其制备方法 |
CN104186838A (zh) * | 2014-08-19 | 2014-12-10 | 安徽孟氏中药饮片有限公司 | 一种保健五色花茶及其制备方法 |
CN104522780A (zh) * | 2014-12-24 | 2015-04-22 | 广州至信中药饮片有限公司 | 降压清肠保健药膳及其制备方法 |
CN105558129A (zh) * | 2015-12-14 | 2016-05-11 | 华坚 | 一种百合养颜茶及其制备方法 |
CN105832890A (zh) * | 2016-05-27 | 2016-08-10 | 孙明香 | 一种防治单纯性肥胖的保健饮品及其制备方法 |
CN106106901A (zh) * | 2016-08-31 | 2016-11-16 | 冯键业 | 养生减肥茶 |
CN109260405A (zh) * | 2017-07-13 | 2019-01-25 | 张巧英 | 一种养生药酒药醋 |
CN111228372A (zh) * | 2020-03-12 | 2020-06-05 | 厦门旗腾文化传媒有限公司 | 一种草本发酵平衡液及其制备方法 |
CN114794467A (zh) * | 2022-04-12 | 2022-07-29 | 广州市沐家健康产业有限公司 | 一种果蔬酵素咀嚼片及其制备方法和应用 |
CN115487268A (zh) * | 2022-09-30 | 2022-12-20 | 广州聚缘堂丹道药业科技有限公司 | 一种促进血液循环和毒素代谢的组合物及其制备方法 |
CN115487268B (zh) * | 2022-09-30 | 2024-03-08 | 广州聚缘堂丹道药业科技有限公司 | 一种促进血液循环和毒素代谢的组合物及其制备方法 |
CN117180340A (zh) * | 2023-11-08 | 2023-12-08 | 吉林华康食元生物科技有限公司 | 一种降血脂的组合物及其制备方法和应用 |
CN117180340B (zh) * | 2023-11-08 | 2024-04-26 | 吉林华康食元生物科技有限公司 | 一种降血脂的组合物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102451363A (zh) | 中草药减肥茶 | |
CN107296949A (zh) | 药食同源复合制剂及其制备方法和应用 | |
CN103263608B (zh) | 一种排毒养颜的中药原粉 | |
CN103416625B (zh) | 一种大麦型仔猪饲料及其制备方法 | |
CN102511867B (zh) | 红枣阿胶枸杞浓浆及其生产工艺 | |
CN105901715A (zh) | 一种鹿胶糕及其制备方法 | |
CN103860969A (zh) | 一种增肥的中药 | |
CN103340266A (zh) | 由植物叶与中药配制的复合保健茶 | |
CN105233100A (zh) | 一种治疗糖尿病的饮料及其制备方法 | |
CN104225361A (zh) | 一种丹七养生酒及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN102511866A (zh) | 红枣阿胶浓浆及其生产工艺 | |
CN103520302B (zh) | 一种沙棘叶抗疲劳胶囊及其制备方法 | |
CN106343091A (zh) | 一种减肥瘦身茶凉茶饮料及其制备方法 | |
CN105249440A (zh) | 一种阿胶糕 | |
CN104873826A (zh) | 一种可清肺祛湿的茶饮及其制备方法 | |
CN102511876A (zh) | 山楂红枣浓浆 | |
CN107343935A (zh) | 一种用于小儿健脾的粉剂及其制备方法 | |
CN101991110A (zh) | 野生灵芝系列食品 | |
CN102511868A (zh) | 一种添加维生素的红枣阿胶浓浆 | |
CN105559076A (zh) | 一种备孕期男性全营养药膳餐糊 | |
CN105543049A (zh) | 一种女性滋补红酒 | |
CN106418015A (zh) | 一种清调食补饮品的配方和制备方法 | |
CN103859118B (zh) | 一种增肥茶 | |
CN103815410A (zh) | 一种调理痤疮酵素及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120516 |